Rapid and ultrasensitive electrochemical detection of circulating tumor DNA by hybridization on the network of gold-coated magnetic nanoparticles.
Dongfei ChenYanfang WuSharmin HoqueRichard David TilleyJohn Justin GoodingPublished in: Chemical science (2021)
An accurate and robust method for quantifying the levels of circulating tumor DNA (ctDNA) is vital if this potential biomarker is to be used for the early diagnosis of cancer. The analysis of ctDNA presents unique challenges because of its short half-life and ultralow abundance in early stage cancers. Here we develop an ultrasensitive electrochemical biosensor for rapid detection of ctDNA in whole blood. The sensing of ctDNA is based on hybridization on a network of probe DNA modified gold-coated magnetic nanoparticles (DNA-Au@MNPs). This DNA-Au@MNPs biosensor can selectively detect short- and long-strand DNA targets. It has a broad dynamic range (2 aM to 20 nM) for 22 nucleotide DNA target with an ultralow detection limit of 3.3 aM. For 101 nucleotide ctDNA target, a dynamic range from 200 aM to 20 nM was achieved with a detection limit of 5 fM. This DNA-Au@MNPs based sensor provides a promising method to achieve 20 min response time and minimally invasive cancer early diagnosis.
Keyphrases
- circulating tumor
- cell free
- circulating tumor cells
- label free
- gold nanoparticles
- magnetic nanoparticles
- early stage
- sensitive detection
- minimally invasive
- quantum dots
- loop mediated isothermal amplification
- papillary thyroid
- reduced graphene oxide
- single molecule
- radiation therapy
- lymph node
- ionic liquid
- high resolution
- microbial community
- antibiotic resistance genes
- silver nanoparticles